HighTower Trust’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | $2.72M | Buy |
8,627
+68
| +0.8% | +$22.9K | 0.27% | 63 |
|
|
2022
Q4 | $3.13M | Buy |
8,559
+1,166
| +16% | +$413K | 0.3% | 55 |
|
|
2022
Q3 | $2.39M | Buy |
+7,393
| New | +$2.34M | 0.26% | 64 |
|
|
2022
Q2 | – | Sell |
-7,918
| Closed | -$2.27M | – | 296 |
|
|
2022
Q1 | $2.27M | Hold |
7,918
| – | – | 0.22% | 67 |
|
|
2021
Q4 | $2.19M | Buy |
+7,918
| New | +$2.01M | 0.21% | 68 |
|
|
2020
Q2 | – | Sell |
-31,557
| Closed | -$4.38M | – | 116 |
|
|
2020
Q1 | $4.38M | Buy |
31,557
+21
| +0.1% | +$2.88K | 0.76% | 32 |
|
|
2019
Q4 | $4.14M | Sell |
31,536
-200
| -0.6% | -$23.2K | 0.51% | 43 |
|
|
2019
Q3 | $3.55M | Sell |
31,736
-180
| -0.6% | -$20K | 0.45% | 45 |
|
|
2019
Q2 | $3.54M | Sell |
31,916
-56,136
| -64% | -$6.61M | 0.45% | 43 |
|
|
2019
Q1 | $11.4M | Sell |
88,052
-276
| -0.3% | -$33.6K | 1.47% | 14 |
|
|
2018
Q4 | $10.2M | Sell |
88,328
-36,928
| -29% | -$4.13M | 1.47% | 13 |
|
|
2018
Q3 | $13.4M | Hold |
125,256
| – | – | 1.5% | 15 |
|
|
2018
Q2 | $10.7M | Sell |
125,256
-1,079
| -0.9% | -$88.6K | 1.24% | 19 |
|
|
2018
Q1 | $9.78M | Sell |
126,335
-10,400
| -8% | -$837K | 1.2% | 22 |
|
|
2017
Q4 | $11.5M | Sell |
136,735
-2,800
| -2% | -$238K | 1.3% | 19 |
|
|
2017
Q3 | $11.9M | Sell |
139,535
-200
| -0.1% | -$16.4K | 1.43% | 19 |
|
|
2017
Q2 | $11.5M | Sell |
139,735
-3,875
| -3% | -$316K | 1.32% | 19 |
|
|
2017
Q1 | $12.1M | Buy |
143,610
+155
| +0.1% | +$12.4K | 1.38% | 15 |
|
|
2016
Q4 | $10.6M | Buy |
143,455
+12,835
| +10% | +$956K | 1.18% | 17 |
|
|
2016
Q3 | $10.5M | Buy |
130,620
+4,285
| +3% | +$343K | 1.18% | 13 |
|
|
2016
Q2 | $9.95M | Buy |
126,335
+23,100
| +22% | +$1.74M | 1.06% | 14 |
|
|
2016
Q1 | $7.43M | Buy |
103,235
+28,759
| +39% | +$2.18M | 0.93% | 19 |
|
|
2015
Q4 | $6.28M | Buy |
74,476
+46,081
| +162% | +$3.82M | 0.84% | 17 |
|
|
2015
Q3 | $2.38M | Buy |
28,395
+12,350
| +77% | +$1.04M | 0.4% | 21 |
|
|
2015
Q2 | $1.34M | Buy |
16,045
+2,651
| +20% | +$202K | 0.21% | 38 |
|
|
2015
Q1 | $973K | Buy |
13,394
+60
| +0.4% | +$4.27K | 0.15% | 47 |
|
|
2014
Q4 | $920K | Buy |
13,334
+567
| +4% | +$38.3K | 0.14% | 51 |
|
|
2014
Q3 | $828K | Sell |
12,767
-7,610
| -37% | -$482K | 0.12% | 52 |
|
|
2014
Q2 | $1.27M | Buy |
20,377
+1,725
| +9% | +$103K | 0.17% | 44 |
|
|
2014
Q1 | $1.1M | Buy |
18,652
+7,671
| +70% | +$428K | 0.15% | 57 |
|
|
2013
Q4 | $560K | Buy |
+10,981
| New | +$550K | 0.07% | 107 |
|
Other funds holding LLY
HighTower Trust's LLY Position: Q1 2023 in Review
HighTower Trust increased its Eli Lilly (LLY) stake by 0.79% in Q1 2023, buying an estimated $22.9K and bringing the position to 8,627 shares worth $2.72M. The position accounts for 0.27% of the portfolio, ranked #63.
HighTower Trust first reported a position in LLY in Q4 2013 and has held it in 31 quarters since. The position peaked at $13.4M in Q3 2018. 2,615 funds tracked by Wall St. Rank hold LLY as of Q1 2023.
- HighTower Trust held 8,627 shares of Eli Lilly worth $2.72M as of Q1 2023.
- HighTower Trust bought 68 Eli Lilly shares in Q1 2023, an estimated $22.9K.
- Eli Lilly made up 0.27% of HighTower Trust's portfolio in Q1 2023, its #63 holding.
- HighTower Trust first reported a position in Eli Lilly in Q4 2013 and has held it in 31 quarters since.
- HighTower Trust's Eli Lilly position peaked at $13.4M in Q3 2018.
- 2,615 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2023.
Based on HighTower Trust's 13F filing for Q1 2023, filed 21 Apr 2023.